Cetnosurge 0.25mg Injection
Marketer
Cipla Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Cetnosurge 0.25mg Injection
Fertigyn 0.25mg Injection, a gonadotropin-releasing hormone antagonist, treats female infertility. It suppresses premature egg release, preventing ovulation. Administered subcutaneously by a healthcare professional, self-injection is prohibited. Your doctor or nurse will guide you on proper at-home injection technique. Dosage and frequency vary depending on the treatment plan; your physician will determine the optimal dose to manage your condition. Continue using this medication as prescribed. Common side effects include injection site reactions (redness, itching, swelling), nausea, and vomiting. Rotate injection sites daily (e.g., abdomen) to minimize irritation. Report dizziness, fainting, abdominal pain, or persistent vomiting immediately. Before commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, breastfeeding, and all other medications you are currently using, as interactions may affect the drug's efficacy or action.
Primary Ingredients of Cetnosurge 0.25mg Injection
No text provided to rephrase.
Uses of Cetnosurge 0.25mg Injection
Inability to conceive in women
Major Benefits of Cetnosurge 0.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cetnosurge 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Cetnosurge 0.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
How Cetnosurge 0.25mg Injection works:
During infertility treatment in women, the premature discharge of immature, unfertilizable eggs can occur. Cetnosurge 0.25mg Injection inhibits a naturally occurring hormone, thereby preventing this premature ovarian egg release.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Cetnosurge 0.25mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Cetnosurge 0.25mg Injection during pregnancy carries a substantial risk. Pregnant individuals should consult their physician; research in animal models and pregnant women reveals considerable harm to the fetus.
Breast feedingUNSAFE
Administration of Cetnosurge 0.25mg Injection is contraindicated while breastfeeding due to potential infant toxicity indicated by available data.
DrivingSAFE
Administration of Cetnosurge 0.25mg Injection typically has no impact on driving capabilities.
KidneyCAUTION
Individuals with impaired kidney function should use Cetnosurge 0.25mg Injection cautiously, potentially requiring a modified dosage. Medical advice is essential. Cetnosurge 0.25mg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should use Cetnosurge 0.25mg Injection cautiously. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cetnosurge 0.25mg Injection :
Omit a Cetnosurge 0.25mg Injection dose? Seek your physician's advice.
Facts to Know About Cetnosurge 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | GnRH receptor antagonists |
3,018 People bought this recently